Beneficial effects of antioxidants in diabetes: Possible protection of pancreatic β-cells against glucose toxicity

Diabetes

Volumn 48, Issue 12, 1999, Pages 2398-2406

  Kaneto, Hideaki ^a   Kajimoto, Yoshitaka ^a   Miyagawa, Jun ichiro ^a   Matsuoka, Taka aki ^a   Fujitani, Yoshio ^a   Umayahara, Yutaka ^a   Hanafusa, Toshiaki ^a   Matsuzawa, Yuji ^a   Yamasaki, Yoshimitsu ^a   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ASCORBIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; GLUCOSE TOLERANCE TEST; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0033499583     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.12.2398     Document Type: Article

References (44)

1. Porte D Jr: Banting lecture 1990: β-cells in type II diabetes mellitus. Diabetes 40:166-180, 1991
2. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-368, 1992
3. Yki-Jarvinen H: Glucose toxicity. Endocrine Rev 13:415-431, 1992
4. Vinik A, Pittenger G, Rafaeloff R, Rosenberg L, Duguid W: Determinants of pancreatic islet cell mass: a balance between neogenesis and senescence/apoptosis. Diabetes Rev 4:235-263, 1996
5. Zangen DH, Bonner-Weir S, Lee CH, Latimer JB, Miller CP, Habener JF, Weir GC: Reduced insulin, GLUT2, and IDX-1 in β-cells after partial pancreatectomy. Diabetes 46:258-264, 1997
6. Robertson RP, Zhang H-J, Pyzdrowski KL, Walseth TF: Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations. J Clin Invest 90:320-325, 1992
7. Olson LK, Redmon JB, Towle HC, Robertson RP: Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein. J Clin Invest 92:514-519, 1993
8. Sharma A, Olson LK, Robertson RP, Stein R: The reduction of insulin gene transcription in HIF-T15β cells chronically exposed to high glucose concentration is associated with loss of RIPE3b 1 and STF-1 transcription factor expression. Mol Endocrinol 9:1127-1134, 1995
9. Poitout V, Olson LK, Robertson RP: Chronic exposure of βTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator. J Clin Invest 97:1041-1046, 1996
10. Moran A, Zhang H-J, Olson LK, Harmon JS, Poitout V, Robertson RP: Differentiation of glucose toxicity from beta cell exhaustion during the evolution of defective insulin gene expression in the pancreatic islet cell line, HIT-T15. J Clin Invest 99:534-539, 1997
11. Ohlsson H, Karlsson K, Edlund T: IPF1, a homeodomain-containing-transactivator of the insulin gene. EMBO J 12:4251-4259, 1993
12. Leonard J, Peers B, Johnson T, Ferreri K, Lee S, Montminy MR: Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells. Mol Endocrinol 7:1275-1283, 1993
13. Miller CP, McGehee RE, Habener JF: IDX-1: a new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene. EMBO J 13:1145-1156, 1994
14. Stoffers DA, Thomas MK, Habener JF: Homeodomain protein IDX-1: a master regulator of pancreas development and insulin gene expression. Trends Endocrinol Metab 8:145-151, 1997
15. Weir GC, Sharma A, Zangen DH, Bonner-Weir S: Transcription factor abnormalities as a cause of beta cell dysfunction in diabetes: a hypothesis. Acta Diabetol 34:177-184, 1997
16. Watada H, Kajimoto Y, Umayahara Y, Matsuoka T, Kaneto H, Fujitani Y, Kamada Y, Kawamori R, Yamasaki Y: The human glucokinase gene β-cell-type promoter an essential role of insulin promoter factor 1 (IPF1)/PDX-1 in its activation in HIT-T15 cells. Diabetes 45:1478-1488, 1996
17. Waeber G, Thompson N, Nicod P, Bonny C: Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. Mol Endocrinol 10:1327-1334, 1996
18. Kaneto H, Miyagawa J, Kajimoto Y, Yamamoto K, Watada H, Umayahara Y, Hanafusa T, Matsuzawa Y, Yamasaki Y, Higashiyama S, Taniguchi N: Expression of heparin-binding epidermal growth factor-like growth factor during pancreas development: a potential role of PDX-1 in transcriptional activation. J Biol Chem 272:29137-29143, 1997
19. Sakurai T, Tsuchiya S: Superoxide production from nonenzymatically glycation protein. FEBS Lett 236:406-410, 1988
20. Hunt JV, Smith CC, Wolff SP: Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39:1420-1424, 1991
21. Myint T, Hoshi S, Ookawara T, Miyazawa N, Suzuki K, Taniguchi N: Immunological detection of glycated proteins in normal and streptozotocin-induced diabetic rats using anti hexitol-lysine IgG. Biochem Biophys Acta 1272:73-79, 1995
22. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
23. Kaneto H, Fujii J, Myint T, Miyazawa N, Islam KN, Kawasaki Y, Suzuki K, Nakamura M, Tatsumi H, Yamasaki Y, Taniguchi N: Reducing sugars trigger oxidative modification and apoptosis in pancreatic β-cells by provoking oxidative stress through the glycation reaction. Biochem J 320:855-863, 1996
24. Tajiri Y, Moller C, Grill V: Long term effects of aminoguanidine on insulin release and biosynthesis: evidence that the formation of advanced glycosylation end products inhibits B cell function. Endocrinology 138:273-280, 1997
25. Ihara Y, Toyokuni S, Uchida K, Odaka H, Tanaka T, Ikeda H, Hiai H, Seino Y, Yamada Y: Hyperglycemia causes oxidative stress in pancreatic β-cells of GK rats, a model of type 2 diabetes. Diabetes 48:927-932, 1999
26. Tiedge M, Lortz S, Drinkgern J, Lenzen S: Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46:1733-1742, 1997
27. Matsuoka T, Kajimoto Y, Watada H, Kaneto H, Kishimoto M, Umayahara Y, Fujitani Y, Kamada T, Kawamori R, Yamasaki Y: Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest 99:144-150, 1997
28. Stahl W, Sies H: Antioxidant defense: vitamins E and C and carotenoids. Diabetes 46 (Suppl. 2):14-18, 1997
29. Hummel KP, Dick MM, Coleman DL: Diabetes, a new mutation in the mouse. Science 153:1127-1128, 1966
30. Coleman DL, Hummel KP: Studies with the mutation, diabetes, in the mouse. Diabetologia 3:238-248, 1966
31. deFrazio A, Leary JA, Hedley DW, Tattersall NHN: Immunohistochemical detection of proliferating cells in vivo. J Histochem Cytochem 35:571-577, 1987
32. Tokuyama Y, Sturis J, DePaoli AM, Takeda J, Stoffel M, Tang J, Sun X, Polonsky KS, Bell GI: Evolution of β-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes 44:1447-1457, 1995
33. Pick A, Clark J, Kubstrup C, Levisetti M, Pugh W, Bonner-Weir S, Polonsky KS: Role of apoptosis in failure of β-cell mass compensation for insulin resistance and β-cell defects in the male Zucker diabetic fatty rat. Diabetes 47:358-364, 1998
34. Rudich A, Tirosh A, Potashnik R, Hemi R, Kanety H, Bashan N: Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes 47:1562-1569, 1998
35. Donath MY, Gross DJ, Cerasi E, Kaiser N: Hyperglycemia-induced β-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48:783-744, 1999
36. Scaglia L, Smith FE, Bonner-Weir S: Apoptosis contributes to the involution of β cell mass in the post partum rat pancreas. Endocrinology 136:5461-5468, 1995
37. Jonsson J, Carlsson L, Edlund T, Edlund H: Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 37:606-609, 1994
38. Offield MF, Jetton TL, Labosky PA, Ray M, Stein RW, Magnuson MA, Hogan BLM, Wright CVE: PDX-1 is required for pancreas outgrowth and differentiation of the rostral duodenum. Development 122:983-995, 1996
39. Waguri M, Yamamoto K, Miyagawa J, Tochino Y, Yamamori K, Kajimoto Y, Nakajima H, Watada H, Yoshiuchi I, Itoh N, Imagawa A, Namba M, Kuwajima M, Yamasaki Y, Hanafusa T, Matsuzawa Y: Demonstration of two different processes of β-cell regeneration in a new diabetic mouse model induced by a selective perfusion of alloxan. Diabetes 46:1281-1290, 1997
40. Sharma A, Zangen DH, Reitz P, Taneja M, Lissauer ME, Miller CP, Weir GC, Habener JF, Bonner-Weir S: The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes 48:507-513, 1999
41. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF: Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 15:106-110, 1997
42. Stoffers DA, Ferrer J, Clarke WL, Habener JF: Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 17:138-139, 1997
43. Dutta S, Bonner-Weir S, Montminy M, Wright C: Regulatory factor linked to late-onset diabetes? Nature 392:560, 1998
44. Sagara M, Satoh J, Wada R, Yagihashi S, Takahashi K, Fukuzawa M, Muto G, Toyota T: Inhibition with N-acetylcysteine of development of peripheral neuropathy in streptozotocin-induced diabetic rats. Diabetologia 39:263-269, 1996